The 15th World Bispecific Summit has established itself as the key biopharma-directed event to gain clear insights into the latest advancements and future directions amongst the mass of bispecific antibodies currently being developed and how to address associated development challenges encountered within this therapeutic modality.

If your research teams are looking to keep ahead of the next wave of bispecific antibodies currently in development, join this event to learn how experts are leveraging pioneering new formats like bispecific ADCs and exciting targets like peptide-HLA complexes whilst managing developability and risk.

Presenting ‘A Review of the Bispecific Landscape: The Past, The Present & The Future of Biologics’ our Research Analyst, Flavio Lima Bianchi will be reviewing drug and trial landscapes, discussing the emerging trends in the space, and looking towards the future of the bispecific industry.

Discover the 3-day agenda and Flavio’s talk in more detail here.